BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 19220306)

  • 1. The in vivo effect of VIP, PACAP-38 and PACAP-27 and mRNA expression of their receptors in rat middle meningeal artery.
    Boni LJ; Ploug KB; Olesen J; Jansen-Olesen I; Gupta S
    Cephalalgia; 2009 Aug; 29(8):837-47. PubMed ID: 19220306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization and expression of VIP and PACAP receptors in isolated cranial arteries of the rat.
    Baun M; Hay-Schmidt A; Edvinsson L; Olesen J; Jansen-Olesen I
    Eur J Pharmacol; 2011 Nov; 670(1):186-94. PubMed ID: 21914446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
    Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
    J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone receptor activation mediates LH-induced type-I pituitary adenylate cyclase activating polypeptide receptor (PAC(1)) gene expression in rat granulosa cells.
    Ko C; Park-Sarge OK
    Biochem Biophys Res Commun; 2000 Oct; 277(1):270-9. PubMed ID: 11027674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of VIP and/or PACAP receptor mRNA in peptide synthesizing cells within the suprachiasmatic nucleus of the rat and in its efferent target sites.
    Kalamatianos T; Kalló I; Piggins HD; Coen CW
    J Comp Neurol; 2004 Jul; 475(1):19-35. PubMed ID: 15176082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
    Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland.
    Mazzocchi G; Malendowicz LK; Rebuffat P; Gottardo L; Nussdorfer GG
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2575-80. PubMed ID: 12050216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PACAP-38 infusion causes sustained vasodilation of the middle meningeal artery in the rat: possible involvement of mast cells.
    Bhatt DK; Gupta S; Olesen J; Jansen-Olesen I
    Cephalalgia; 2014 Oct; 34(11):877-86. PubMed ID: 24563332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
    Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R
    Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium signal-mediated expression of the vasoactive intestinal polypeptide gene and its small contribution to activity-dependent survival of mouse cerebellar granule cells.
    Fukuchi M; Sakuragawa S; Tabuchi A; Tsuda M
    J Neurosci Res; 2004 Jul; 77(1):26-34. PubMed ID: 15197736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous ligands of PACAP/VIP receptors in the autocrine-paracrine regulation of the adrenal gland.
    Conconi MT; Spinazzi R; Nussdorfer GG
    Int Rev Cytol; 2006; 249():1-51. PubMed ID: 16697281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC/PAC receptor pharmacology.
    Dickson L; Aramori I; McCulloch J; Sharkey J; Finlayson K
    Neuropharmacology; 2006 Nov; 51(6):1086-98. PubMed ID: 16930633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery.
    Chan KY; Baun M; de Vries R; van den Bogaerdt AJ; Dirven CM; Danser AH; Jansen-Olesen I; Olesen J; Villalón CM; MaassenVanDenBrink A; Gupta S
    Cephalalgia; 2011 Jan; 31(2):181-9. PubMed ID: 20974589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue.
    García-Fernández MO; Collado B; Bodega G; Cortés J; Ruíz-Villaespesa A; Carmena MJ; Prieto JC
    Gynecol Endocrinol; 2005 Jun; 20(6):327-33. PubMed ID: 16019382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of VPAC1 receptors by VIP and PACAP-27 in human bronchial epithelial cells induces CFTR-dependent chloride secretion.
    Dérand R; Montoni A; Bulteau-Pignoux L; Janet T; Moreau B; Muller JM; Becq F
    Br J Pharmacol; 2004 Feb; 141(4):698-708. PubMed ID: 14744818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PACAP and its receptors in cranial arteries and mast cells.
    Jansen-Olesen I; Hougaard Pedersen S
    J Headache Pain; 2018 Feb; 19(1):16. PubMed ID: 29460121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
    Nagata A; Tanaka T; Minezawa A; Poyurovsky M; Mayama T; Suzuki S; Hashimoto N; Yoshida T; Suyama K; Miyata A; Hosokawa H; Nakayama T; Tatsuno I
    J Cell Physiol; 2009 Oct; 221(1):75-83. PubMed ID: 19496170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.